ALB and hepatocellular carcinoma: Albumin stratification of TTP outcomes in these optimal patients revealed patients with albumin ≥ 3.4 g/dL prior to first cycle LDT had 1-year HCC progression rates < 2% compared to 11% with albumin < 3.4 g/dL.